What is Multiply Labs?
Multiply Labs specializes in the development of advanced robotic systems tailored for the industrial-scale production of precision medicines, with a particular focus on cell therapies. Their innovative technology is designed to enhance throughput and flexibility in manufacturing processes, aiming to democratize access to next-generation therapies for patients worldwide. The company's solutions are targeted at life sciences organizations seeking to optimize their production capabilities.
How much funding has Multiply Labs raised?
Multiply Labs has raised a total of $22.8M across 2 funding rounds:
Private Equity
$2.8M
Series A
$20M
Private Equity (2016): $2.8M with participation from CRCM Ventures, P101, Graph Ventures, and Fenox Venture Capital
Series A (2021): $20M led by Fifty Years, Founders Fund, Pathfinder International, Garage Capital Ventures, Casdin Capital, and Lux Capital
Key Investors in Multiply Labs
CRCM Ventures
CRCM Ventures is a San Francisco-based investment advisory firm established in 2012, known for providing tailored financial strategies to its clients. The firm is registered with the U.S. Securities and Exchange Commission (SEC).
Fifty Years
Fifty Years is a venture capital firm focused on pre-seed and seed-stage investments, supporting founders who use technology to solve major global issues in areas like climate change and disease. They assist scientists and engineers in launching deep tech startups.
Founders Fund
Founders Fund is a venture capital firm that invests in significant companies globally across various sectors and stages. Its partners have a track record of founding and funding major tech companies like SpaceX and Palantir.
What's next for Multiply Labs?
The substantial enterprise-level funding, including the recent strategic investment, positions Multiply Labs for significant scaling and further technological development. This capital infusion is expected to accelerate the company's mission to industrialize cell therapy manufacturing, potentially leading to broader adoption of their robotic solutions across the life sciences sector. Future growth will likely involve expanding manufacturing capacity, enhancing robotic automation capabilities, and forging strategic partnerships to reach a wider market.
See full Multiply Labs company page
